Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Clin Exp Dermatol ; 43(7): 775-781, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29952106

ABSTRACT

BACKGROUND: Various trials have been conducted on the management of male pattern hair loss (MPHL), but the outcomes often seem to be limited. Adjuvant therapies are urgently needed. AIM: To evaluate the efficacy and safety of combined fractional radiofrequency microneedling (FRM) and 5% topical minoxidil in the treatment of male pattern hair loss. METHODS: In total, 19 Chinese men were enrolled in this randomized, controlled, split-scalp trial. Participants received monotherapy with 5% topical minoxidil twice daily to one half of the scalp, while on the other half of the scalp the treatment with twice-daily 5% topical minoxidil was combined with five sessions of FRM at 4-week intervals. Mean hair count and hair thickness, global assessment by the investigators, subject self-assessment and adverse effects were assessed. RESULTS: After 5 months of treatment, mean hair count increased from 44.12 ± 21.58 to 73.14 ± 25.45 on the combined-therapy side and from 46.22 ± 18.77 to 63.21 ± 19.22 on the monotherapy side, while mean hair thickness increased from 53 ± 13 µm to 71 ± 15 µm and from 52 ± 16 µm to 66 ± 14 µm, respectively. Compared with the monotherapy side, the combined-therapy side had a higher degree of improvement in both hair count (P = 0.01) and hair thickness (P = 0.02). CONCLUSIONS: Combined treatment with fractional radiofrequency microneedle and 5% topical minoxidil could be an effective and safe treatment option for male pattern hair loss.


Subject(s)
Alopecia/drug therapy , Alopecia/radiotherapy , Cosmetic Techniques , Minoxidil/therapeutic use , Radiofrequency Therapy , Administration, Topical , Adult , Combined Modality Therapy , Cosmetic Techniques/instrumentation , Humans , Male , Middle Aged , Needles , Pulsed Radiofrequency Treatment , Scalp , Young Adult
3.
Zhonghua Gan Zang Bing Za Zhi ; 25(5): 349-353, 2017 May 20.
Article in Zh | MEDLINE | ID: mdl-28763841

ABSTRACT

Objective: To investigate the molecular markers of copy number aberrations (CNAs) of genes related to extrohepatic metastasis-free survival after the operation for hepatocellular carcinoma (HCC). Methods: The CNA status of 20 candidate genes in 66 HCC samples was detected by microarray comparative genomic hybridization. The associations between gene CNAs and extrohepatic metastasis-free survival were evaluated using the Cox regression model, Log-rank test, and Kaplan-Meier survival analysis. Results: Multivariate Cox analysis revealed that the independent risk factors for metastasis-free survival were MDM4 gain (hazard ratio [HR] = 2.74, 95% confidence interval [CI] = 1.18-6.37, P < 0.05), APC loss (HR = 8.43, 95% CI = 2.48-28.66, P < 0.01), and BCL2L1 gain (HR = 3.45, 95% CI = 1.13-10.52, P < 0.05) and the independent protective factor was FBXW7 loss (HR = 0.32, 95% CI = 0.12-0.89, P < 0.05). By stepwise Cox regression analysis, three CNAs related to metastasis-free survival were screened out: MDM4 gain (HR = 2.71, 95% CI = 1.11-6.64, P < 0.05), APC loss (HR = 7.19, 95% CI = 1.88-27.60, P < 0.005), and FBXW7 loss (HR = 0.16, 95% CI = 0.05-0.46, P < 0.01). There were significant differences in metastasis-free survival rate between the HCC patients with FBXW7 loss and without MDM4 gain or APC loss, those with MDM4 gain and/or APC loss and without FBXW7 loss, and those with other CNA combinations (log-rank test, P < 0.01). Conclusion: MDM4 gain, APC loss, and FBXW7 loss are the independent prognostic factors for extrohepatic metastasis-free survival after the operation for HCC and can be used to predict the risk of extrohepatic metastasis after the operation for HCC.


Subject(s)
Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/surgery , F-Box-WD Repeat-Containing Protein 7/genetics , Liver Neoplasms/genetics , Liver Neoplasms/surgery , Nuclear Proteins/genetics , Proto-Oncogene Proteins/genetics , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/pathology , Cell Cycle Proteins , Comparative Genomic Hybridization , DNA Copy Number Variations/genetics , Disease-Free Survival , F-Box-WD Repeat-Containing Protein 7/metabolism , Humans , Kaplan-Meier Estimate , Liver Neoplasms/mortality , Liver Neoplasms/pathology , Nuclear Proteins/metabolism , Prognosis , Proportional Hazards Models , Proto-Oncogene Proteins/metabolism , Survival Analysis , Treatment Outcome
5.
Gene Ther ; 17(1): 4-13, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19759567

ABSTRACT

This study explores the effect of priming rhesus monkeys with an Ad5/35 vector expressing simian immunodeficiency virus (SIV) gag and gp120, and then boosting the animals with an modified vaccinia virus Ankara (MVA) vector encoding the same antigens after a 2-month interval. The animals were intravenously challenged with 100 TCID50 of highly pathogenic SIVmac239 virus 2 months after the booster vaccination. The priming vaccination induced robust SIV-specific cell-mediated and humoral immune responses, and boosting further enhanced the cellular immunity. Vaccination reduced peak and long-term viral loads by 1-2 logs for a period of >6 months, as reflected by a reduction in both the SIV RNA and DNA levels. Of considerable interest, the immunized monkeys did not suffer from loss of CD4 T cells, particularly central memory CD4 T cells. These results demonstrate that prophylactic vaccination with Ad5/35 followed by MVA reduces viral replication and prevents CD4 T-cell loss, and that these effects may decrease the likelihood of disease progression.


Subject(s)
Adenoviridae/genetics , Genetic Vectors , Immunization, Secondary , SAIDS Vaccines/therapeutic use , Simian Acquired Immunodeficiency Syndrome/prevention & control , Vaccinia virus/genetics , Animals , Genes, gag , Immunity, Cellular , Immunity, Humoral , Immunization Schedule , Macaca mulatta , Membrane Glycoproteins/genetics , SAIDS Vaccines/immunology , T-Lymphocytes/immunology , Viral Envelope Proteins/genetics , Viral Load
6.
Mol Inform ; 37(4): e1700081, 2018 04.
Article in English | MEDLINE | ID: mdl-29106044

ABSTRACT

The discovery of biomarkers from high-dimensional data is a very challenging task in cancer diagnoses. On the one hand, biomarker discovery is the so-called high-dimensional small-sample problem. On the other hand, these data are redundant and noisy. In recent years, biomarker discovery from high-throughput biological data has become an increasingly important emerging topic in the field of bioinformatics. In this study, we propose a binary differential evolution algorithm for feature selection. Firstly, we suggest using a two-stage approach, where three filter methods including the Fisher score, T-statistics, and Information gain are used to generate the feature pool for input to differential evolution (DE). Secondly, in order to improve the performance of differential evolution algorithm for feature selection, a new variant of binary DE called BDE is proposed. Three optimization strategies are incorporated into the BDE. The first strategy is the heuristic method in initial stage, the second one is the self-adaptive parameter control, and the third one is the minimum change value to improve the exploration behaviour thus enhance the diversity. Finally, Support vector machine (SVM) is used as the classifier in 10 fold cross-validation method. The experimental results of our proposed algorithm on some benchmark datasets demonstrate the effectiveness of our algorithm. In addition, the BDE forged in this study will be of great potential in feature selection problems.


Subject(s)
Biomarkers, Tumor/genetics , Computational Biology/methods , Evolution, Molecular , Support Vector Machine , Biomarkers, Tumor/analysis , Humans
7.
Ann N Y Acad Sci ; 858: 270-5, 1998 Sep 11.
Article in English | MEDLINE | ID: mdl-9917824

ABSTRACT

In order to meet the need of trachea transplantation for clinical application, it is important to research the methods of cryopreservation and transplantation of trachea. By the thermal analyses and thermal control techniques, combined with electron microscopy, the effects of cooling and warming rates with different concentrations of cryoprotective agents were studied. Also the transplantation technique was studied, eighty five percent (17/20) of the dogs were survival after the transplantation with cryopreserved tracheas.


Subject(s)
Cryopreservation/methods , Graft Survival , Trachea , Transplantation, Homologous/physiology , Animals , Cryopreservation/instrumentation , Cryoprotective Agents , Dimethyl Sulfoxide , Dogs , Glycerol , Microscopy, Electron , Trachea/transplantation , Trachea/ultrastructure
8.
Chin Med J (Engl) ; 104(3): 237-43, 1991 Mar.
Article in English | MEDLINE | ID: mdl-2065538

ABSTRACT

Five cases of pseudoxanthoma elasticum (PXE) found in one family are reported. The hereditary pattern is probably of autosomal dominant type 2. In the fundi of all the 5 cases, mottlings of the retinal pigment epithelium or orange skin-like lesions in both eyes which are of significant diagnostic importance are seen. The fundus changes are more prominent when skin lesions are typical. Under electron and light microscope, the pathological changes of clinically typical and atypical lesions show similar characteristics of this disorder. Remarkable calcification of elastic fibers with abnormal contour and fragmentation, destruction of mitochondria of fibroblasts and a great number of mast cells leaning against fibroblasts are the chief findings in the histochemically stained specimens. The pathogenetic mechanism of this disorder is possibly dystrophy of elastic fibers with its inherent nature of being easily calcified. Involvement of autoimmune factors in the pathogenesis is quite possible.


Subject(s)
Pseudoxanthoma Elasticum/genetics , Adult , Elastic Tissue/ultrastructure , Female , Humans , Male , Pedigree , Pseudoxanthoma Elasticum/pathology , Skin/ultrastructure
9.
Chin Med J (Engl) ; 106(10): 773-82, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8033612

ABSTRACT

A case of sympathetic ophthalmia (SO) is reported. A long lasting stable result was obtained for this patient treated basically with traditional Chinese medicine. His exciting eye was investigated under light and transmission electron microscopes. Prominent granulomatous lesions in the choroid, Dalen-Fuchs nodules (DFNs) and disruption of outer and inner basement membrane of Bruch's membrane under DFNs are found, plasma cells are not few and melanocytes and retinal pigment epithelial cells are possibly the target cells. In various cells, nuclear bodies (NBs) are ubiquitous and sometimes multiple in an individual cell nucleus. Microtubule-like structures are present inside and outside the NBs and parallel lines composed of relatively uniform high electron dense granules as lattice-like structures can be seen. It was surmised that a virus induced autoimmune process might be involved in the pathogenesis of SO.


Subject(s)
Drugs, Chinese Herbal/therapeutic use , Ophthalmia, Sympathetic/pathology , Pigment Epithelium of Eye/ultrastructure , Uvea/ultrastructure , Adult , Autoimmune Diseases , Humans , Male , Microscopy, Electron , Ophthalmia, Sympathetic/drug therapy , Ophthalmia, Sympathetic/microbiology , Virus Diseases
10.
Chin Med J (Engl) ; 103(2): 134-41, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2118030

ABSTRACT

A family with Fabry's disease including 2 hemizygotes and 3 heterozygotes is reported. The ocular manifestations include tortuosity of conjunctival vessels, Fabry's deposits underlying the anterior capsule of the lens and the whorl-like corneal dystrophy. Foam cells or mulberry cells in the urinary sediment and varying numbers of high electron-dense inclusions in the cytoplasm of endothelial cells in skin lesions are also important in diagnosing this disease. The concentrations of lipid peroxide in the sera of 2 hemizygotes in this report were higher than normal, possibly due to the patients weak ability of anti-oxygenation and malfunction of cells whose plasma membranes are easily attacked by free oxygen radicals. The biochemical and pathological changes, diagnosis, treatment, genetics and prevention of the disease are discussed.


Subject(s)
Fabry Disease/genetics , Skin/ultrastructure , Adult , Biopsy , Conjunctiva/blood supply , Eye/pathology , Fabry Disease/pathology , Fabry Disease/ultrastructure , Female , Humans , Lens, Crystalline/pathology , Male , Pedigree , Retinal Vessels/pathology , Skin/pathology , Venules/pathology
SELECTION OF CITATIONS
SEARCH DETAIL